Pharma Marketing Blog critiques a Rozerem ad, and suspects the drug/advertising company is fighting back in the comments section.
Related Stories
More in Uncategorized
Comments
- Daniel Haszard
- Orac
Previous post: Meet the oldest MD in the country
Next post: The future of Grand Rounds




